The unresolved riddle of glucocorticoid withdrawal

Journal of Endocrinological Investigation
F Guerrero PérezC Villabona Artero

Abstract

Glucocorticoid (GC) therapy is the most common cause of adrenal insufficiency (AI). The real prevalence of AI after GC is unknown but it could involve more than 30% of patients. Some gene variation has been associated with the variability of hypothalamic-pituitary-adrenal (HPA) axis and this issue could contribute to the individual variation of adrenal function after GC treatment. Symptoms and signs of AI are nonspecific and frequently the diagnosis is delayed. Dosage, duration of treatment, administration route and serum cortisol value are not completely useful to predict AI. Clinical estimation of HPA suppression is difficult and biochemical testing is needed to confirm the diagnosis of AI. The different tapering regimens are based on a very low quality of evidence and considering the sizable individual variation, it is improbable that future research will find a secure GC tapering schedule for all patients. The aim of this review is to address the most important aspects in management of GC withdrawal in light of current knowledge.

References

Jan 1, 1976·Medicine·L Axelrod
Apr 1, 1991·The Journal of Clinical Endocrinology and Metabolism·G DicksteinM Lahav
Feb 1, 1980·The American Journal of Medicine·R B Dixon, N P Christy
Oct 17, 1996·The New England Journal of Medicine·W Oelkers
Oct 12, 1999·JAMA : the Journal of the American Medical Association·A S Krasner
Mar 4, 2000·QJM : Monthly Journal of the Association of Physicians·T P van StaaC Cooper
Apr 30, 2002·American Journal of Clinical Dermatology·Cheryl Levin, Howard I Maibach
Feb 21, 2003·The New England Journal of Medicine·Mark S Cooper, Paul M Stewart
May 3, 2003·The Journal of Clinical Endocrinology and Metabolism·Helena K GleesonPaul L Padfield
Aug 16, 2003·Endocrine Reviews·Ze'ev HochbergGeorge P Chrousos
Mar 1, 1960·The Journal of Clinical Endocrinology and Metabolism·T T AMATRUDAP K BONDY
Nov 7, 2003·The Journal of Clinical Endocrinology and Metabolism·Mona P Nasrallah, Baha M Arafah
Jan 13, 2006·Clinical Endocrinology·Rebecca M ReynoldsPaul L Padfield
Apr 29, 2008·Current Opinion in Endocrinology, Diabetes, and Obesity·Gabriel Dickstein, Leonard Saiegh
Aug 14, 2008·The Journal of Clinical Endocrinology and Metabolism·Rasa KazlauskaiteUNKNOWN Consortium for Evaluation of Corticotropin Test in Hypothalamic-Pituitary Adrenal Insufficiency
Nov 4, 2008·Acta Paediatrica·Liisa KrögerJarmo Jääskeläinen
Dec 3, 2008·Nature Clinical Practice. Endocrinology & Metabolism·Paul M Stewart, Penelope M Clark
May 29, 2009·The New England Journal of Medicine·Stefan R Bornstein
Jul 3, 2009·Neuroimmunomodulation·Roel H Derijk
Apr 20, 2010·The American Journal of the Medical Sciences·Benjamin BleickenMarcus Quinkler
Jul 21, 2012·Clinical Endocrinology·Warrick J InderAnthony Russell
Jun 29, 2013·European Journal of Internal Medicine·Stina DinsenUlla Feldt-Rasmussen
Aug 8, 2014·The Lancet. Diabetes & Endocrinology·Irina BancosWiebke Arlt
Apr 7, 2015·The Journal of Clinical Endocrinology and Metabolism·Leonie H A BroersenOlaf M Dekkers
Dec 10, 2015·The Journal of Clinical Endocrinology and Metabolism·Naykky Singh OspinaM Hassan Murad
Dec 18, 2015·Endocrinology and Metabolism·Jong Ha BaekJaehoon Jung
May 24, 2016·Frontiers of Hormone Research·Lisanne C C J Smans, Pierre M J Zelissen
May 24, 2016·Frontiers of Hormone Research·Federica GuaraldiRoberta Giordano

❮ Previous
Next ❯

Citations

Jul 28, 2018·Endocrine Connections·Filippo CeccatoCarla Scaroni
Oct 10, 2018·Endocrine Connections·Filippo CeccatoCarla Scaroni
May 8, 2018·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·Sébastien Préville-RatelleYves Berthiaume

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.